MARKET

PLSE

PLSE

Pulse Biosciences Inc
NASDAQ
16.03
-1.09
-6.37%
After Hours: 16.59 +0.56 +3.49% 17:25 07/11 EDT
OPEN
17.00
PREV CLOSE
17.12
HIGH
17.00
LOW
15.77
VOLUME
116.22K
TURNOVER
--
52 WEEK HIGH
25.00
52 WEEK LOW
13.05
MARKET CAP
1.08B
P/E (TTM)
-16.5411
1D
5D
1M
3M
1Y
5Y
1D
Pulse Biosciences Price Target Announced at $22.00/Share by Oppenheimer
Dow Jones · 5d ago
Oppenheimer Initiates Coverage On Pulse Biosciences with Outperform Rating, Announces Price Target of $22
Benzinga · 5d ago
Pulse Biosciences initiated with an Outperform at Oppenheimer
TipRanks · 5d ago
Weekly Report: what happened at PLSE last week (0630-0704)?
Weekly Report · 5d ago
Weekly Report: what happened at PLSE last week (0623-0627)?
Weekly Report · 06/30 10:22
Weekly Report: what happened at PLSE last week (0616-0620)?
Weekly Report · 06/23 10:18
Insider Sale: Chief Technology Officer of $PLSE Sells 15,000 Shares
NASDAQ · 06/17 00:31
Weekly Report: what happened at PLSE last week (0609-0613)?
Weekly Report · 06/16 10:22
More
About PLSE
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s CellFX Nanosecond Pulsed-Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. It is pursuing the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation (AF) and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers, such as surgical soft tissue ablation. Its nsPFA Percutaneous Electrode System consists of a disposable, percutaneous, needle electrode for use with its CellFX Console. Its surgical cardiac ablation clamp is designed for use by cardiac surgeons during the surgical treatment of AF. The CellFX Console is a tunable, software-enabled, console-based platform, designed to accommodate the clinical workflow preferred by physicians. It is also developing a Nanosecond PFA 360-degree Cardiac Catheter System.

Webull offers Pulse Biosciences Inc stock information, including NASDAQ: PLSE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PLSE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PLSE stock methods without spending real money on the virtual paper trading platform.